OSR Health, Inc. (OSRH)
OTC: OSRH · Surgical & Medical Instruments & Apparatus · Bellevue, WA · filing with the SEC since 2021
Filings
194 filings since 2017 beside 34 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jul 16, 2026.
Filings a yearinsider forms included
61457595735
2026 counts to Nov 13, 2026.
Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Nov 13, 2026.Listing warning from its exchange (8-K item 3.01): 9 times in the last 36 months, the newest Oct 28, 2026.Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Oct 2, 2026.SEC letters: 16 in the last 36 months, the newest Jun 12, 2025.A late-filing notice, Form NT 10-Q, filed May 15, 2025.A late-filing notice, Form NT 10-K, filed Apr 1, 2025.A late-filing notice, Form NT 10-Q, filed Aug 15, 2024.A late-filing notice, Form NT 10-K, filed Apr 2, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 13, 2026
10-Q
Quarterly reportThe SI's read OSR Health reported net sales of $524,793 for the quarter ended September 30, 2026, down from $627,747 a year earlier, with a net loss of $1,909,126 and cash of $1,368,312. Nasdaq suspended trading on August 26, 2026 over the minimum bid price rule, and on October 23, 2026 the Hearings Panel decided to delist the shares, which now trade on the OTC Pink market. Falling sales, ongoing losses and the loss of the Nasdaq listing make this concerning.
Sep 30, 2026
Nov 13, 2026
8-K items 4.01, 9.01
Auditor change · Current reportThe SI's read OSR Health's auditor, Shinhan Accounting Corporation, resigned on November 6, 2026, saying overdue fees for its audit of the 2025 financial statements may threaten its independence. Its last report carried a going concern paragraph, meaning the auditor doubted the company could keep paying its bills, and the company has disclosed material weaknesses in its financial controls. The tag is concerning because an auditor leaving over unpaid fees points to cash strain and leaves the company without an auditor until a successor is hired.
Nov 6, 2026
Oct 28, 2026
8-K items 3.01, 7.01, 9.01
Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report
Oct 23, 2026
Aug 19, 2026
8-K items 3.01, 7.01, 9.01
Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report
Jun 17, 2026
8-K items 5.03, 9.01
Charter, bylaw or fiscal-year change · Current report
Jun 11, 2026
May 6, 2026
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
Apr 29, 2026
Apr 30, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Apr 29, 2026
Apr 9, 2026
8-K items 1.01, 2.03, 3.02, 7.01, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Apr 7, 2026
Apr 3, 2026
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
Mar 27, 2026
Jan 27, 2026
8-K items 2.01, 7.01, 9.01
Purchase or sale of a business completed; Investor disclosure (Regulation FD) · Current report
Jan 26, 2026
Jan 14, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Jan 13, 2025
Nov 25, 2025
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Nov 21, 2025
Oct 16, 2025
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Oct 13, 2025
40 of 194 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.